- TUI (TUI1 TH) +4%
- TUI Sees 2024 Underlying Ebit at Least +25%
- Evotec SE (EVT TH) +2.5%
- Evotec Partner Jingxin Gets Approval for EVT201 in China
- AMS-Osram (DQW1 TH) +1.5%
- Rolls-Royce (RRU TH) +1.5%
- Anglo American (NGLB TH) +1.3%
- Glencore (8GC TH) +1%
- Delivery Hero (DHER TH) +1%
- Rio Tinto (RIO1 TH) +0.8%
- Carl Zeiss Meditec (AFX TH) +0.7%
- BP (BPE5 TH) -1%
- Fresenius Medical Care A (FME TH) -1%
- Fresenius to Access Up to €300M in Govt Funds Over Energy Costs
- Nemetschek (NEM TH) -1.3%
- Sanofi (SNW TH) -1.5%
- Merck KGaA’s Evobrutinib Trial Failure a Surprise: Street Wrap
- Endesa (ENA TH) -1.7%
- Nokia (NOA3 TH) -2.1%
- Fresenius SE (FRE TH) -3.4%
- Fresenius to Access Up to €300M in Govt Funds Over Energy Costs
- Volvo (VOL1 TH) -3.7%
- Volvo Cut to Neutral at BNPP Exane; PT 250 kronor
- Nel (D7G TH) -5.3%
- Nel Cut to Equal-Weight at Morgan Stanley; PT 9 kroner
- Merck KGaA (MRK TH) -11%
- Merck KGaA’s Multiple Sclerosis Drug Fails Late-Stage Trials